SHIJIAZHUANG SAGACITY NEW DRUG DEV COMPANY LTD has a total of 14 patent applications. Its first patent ever was published in 2019. It filed its patents most often in Canada, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SELVITA S A, GUANGDONG RAYNOVENT BIOTECH CO LTD and AFASCI INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Brazil | 2 | |
#4 | China | 2 | |
#5 | United States | 2 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Wu Lingyun | 5 |
#2 | Li Weidong | 5 |
#3 | Zhang Peng | 5 |
#4 | Li Jian | 4 |
#5 | Li Jie | 4 |
#6 | Wang Jian | 4 |
#7 | Qian Wenyuan | 4 |
#8 | Chen Shuhui | 4 |
#9 | Xu Yu | 2 |
#10 | Lei Maoyi | 2 |
Publication | Filing date | Title |
---|---|---|
CN111712499A | ATR inhibitor and application thereof | |
CN111683946A | Crystal form and salt form of tricyclic compound and preparation method thereof |